Laparoscopic sleeve gastrectomy with transit bipartition in a treatment of obesity, type II diabetes mellitus and GERD
https://doi.org/10.31146/1682-8658-ecg-182-10-83-87
Abstract
The aim: to analyze the eff ectiveness of laparoscopic sleeve gastrectomy with transit bipartition in patients with obesity, weighted type II diabetes mellitus and gastroesophageal refl ux.
Material and methods: 22 patients were operated on from 12.2017 to 02.2020. The average BMI is 44 ± 4.6 kg / m2. M: F — 1: 4. The average age is 45 ± 7.1 years. The terms of postoperative observation ranged from 1 to 24 months. The analysis of the immediate and long-term results of surgical treatment.
Results: Laparoscopic sleeve gastrectomy with double transit is an eff ective and relatively simple operation for the treatment of patients with obesity, type II diabetes mellitus and gastroesophageal refl ux, the eff ect is comparable to gastric bypass, Sadi operation, at the same time leads to early saturation, rapid loss of body weight and low malabsorption eff ect.
About the Authors
V. A. Anischenko
Medical center AVICENNA;
Public budgetary educational institution of higher education “Novosibirsk State Medical University” of the Ministry of Healthcare of the Russia
Russian Federation
Head of the Department of Surgery of training and retraining of doctors, Doctor of Medical Sciences, Professor
Russian Federation
Head of the Department of Surgery of training and retraining of doctors, Doctor of Medical Sciences, Professor
630099, Russia, Novosibirsk, Kommunisticheskaya street, 17/1
630091, Novosibirsk, Krasnyj prospect, 52
D. A. Kim
Medical center AVICENNA;
Public budgetary educational institution of higher education “Novosibirsk State Medical University” of the Ministry of Healthcare of the Russia
Russian Federation
Russian Federation
assistant of the Department of Surgery of training and retraining of doctors, PhD
630099, Russia, Novosibirsk, Kommunisticheskaya street, 17/1
630091, Novosibirsk, Krasnyj prospect, 52
O. A. Shumkov
Research Institute of Clinical and Experimental Lymphology - a branch of the Federal Research Center for Cytology and Genetics SB RAS
Russian Federation
Russian Federation
Leading Researcher, Doctor of Medical Sciences
630117, Russia, Novosibirsk, Timakova street, 2
A. A. Smagin
Public budgetary educational institution of higher education “Novosibirsk State Medical University” of the Ministry of Healthcare of the Russia;
Research Institute of Clinical and Experimental Lymphology - a branch of the Federal Research Center for Cytology and Genetics SB RAS
Russian Federation
Russian Federation
head of the laboratory, professor of the Department of Anesthesiology and Reanimatology named after prof. I. P. Vereshchagina, Doctor of Medical Sciences, Professor
630091, Novosibirsk, Krasnyj prospect, 52
630117, Russia, Novosibirsk, Timakova street, 2
References
1. Sedov V. M., Fishman M. B. Laparoscopic surgery of obesity: A practical guide. Atlas. SPb. 2009, 192 p.
2. Mui W. L., Lee W. D., Lam K. Laparoscopic sleeve gastrectomy with loop bipartition: A novel metabolic operation in treating obese type II diabetes mellitus. International journal of surgery case reports. 2013, no.5, pp.56–58. DOI: 10.1016/j.ijscr.2013.12.002.
3. Madsbad S., Dirksen C., Holst J. J. Mechanisms of changes in glu cose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014, no.2 (2), pp.152–164. DOI: 10.1016/s2213–8587(13)70218–3.
4. Mahdy T., Wahedi A. W., Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: A Retrospective Cohort Study. International journal of surgery. 2016, no. 34, pp. 28–34. DOI: 10.1016/j.ijsu.2016.08.018.
5. Raveendran A. V., Shiji P. V., Pappachan J. M. Role Of Bariatric Surgery In Type 2 Diabetes. BMH Med. J. 2017, no. 4(1), pp.6–16.
6. Salukhov V. V., Ilinsky N. S., Vasiliev E. V., Sardinov R. T. et al. Possibilities of metabolic surgery in the treatment of type 2 diabetes mellitus in patients with grade 1 alimentary obesity. Diabetes mellitus. 2018;21(1):15–25. DOI: 10.14341/DM9292
7. Fishman M. B., Ma Chie, Muzhikov S. P. Prevention of gastroesophageal reflux disease after bariatric interventions. Bulletin of surgery. 2014, No. 3, pp. 33–37. DOI: 10.24884/0042–4625–2014–173–3–33–37.
8. Reis de Azevedo F., Santoro S., Corrêa-Giannella M. L., et al. A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition. Obesity Surgery. 2018, no. 28, pp. 16–25. DOI: 10.1007/s11695–018–3239–3.
9. Santoro S., Milleo F. Q., Malzoni C. E ., et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008, no. 18, pp.17–26.
10. Vennapusa A., Prk B., MSS M. A Feasibility Study of Novel “Laparoscopic Sleeve Gastrectomy with Loop Gastroileal Bypass” for Obesity: An Indian experience. International Surgery. 2018, Vol. 102, no.11. DOI: 10.9738/INTSURG-D-18–00007.1
11. Kassem M. A., Durda M. A., Stoicea N., et al. The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events. Front Endocrinol. 2017, no. 8, pp.37. DOI: 10.3389/fendo.2017.00037.
Review
For citations:
Anischenko V.A., Kim D.A., Shumkov O.A., Smagin A.A. Laparoscopic sleeve gastrectomy with transit bipartition in a treatment of obesity, type II diabetes mellitus and GERD. Experimental and Clinical Gastroenterology. 2020;(10):83-87. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-182-10-83-87
Views:
694
Email this article 